Catalyst Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CBIO and buy or sell other stocks, options, and ETFs commission-free!

About CBIO

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). 

CEO
Han Ying, PhD
CEOHan Ying, PhD
Employees
7
Employees7
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1997
Founded1997
Employees
7
Employees7

CBIO Key Statistics

Market cap
19.42M
Market cap19.42M
Price-Earnings ratio
-0.99
Price-Earnings ratio-0.99
Dividend yield
Dividend yield
Average volume
55.99K
Average volume55.99K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$30.40
52 Week high$30.40
52 Week low
$3.00
52 Week low$3.00
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.